Olivier Brandicourt (Sipa via AP Images)

Black­stone en­lists a mur­der­ers' row of ad­vi­sors, in­clud­ing ex-Sanofi CEO Olivi­er Brandi­court, to steer life sci­ences biz

Among the biggest in­sti­tu­tion­al in­vestors in the cur­rent biotech craze, Black­stone has been un­afraid to throw its weight around with a ded­i­cat­ed life sci­ences arm plac­ing some hefty bets. Now, hop­ing to get a leg up in ther­a­peu­tics and be­yond, the firm is draft­ing four ex­ec­u­tives with lengthy ré­sumés in­to the fight.

Black­stone Life Sci­ences has fleshed out its se­nior ad­vi­so­ry team with the ap­point­ments of ex-Sanofi CEO and di­rec­tor Olivi­er Brandi­court, NPS Phar­ma vet­er­an Fran­cois Nad­er, for­mer GE Health­care and Medtron­ic CEO Omar Ishrak, and for­mer Ge­nom­ic Health CEO Kim Popovits, the in­vest­ment gi­ant said Tues­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.